European stock markets exhibited muted performance, with gains in cyclical sectors such as automotive and chemicals counterbalancing declines in technology shares. Novo Nordisk's stock plummeted 17% following the release of a surprisingly disappointing sales forecast.

The Stoxx Europe 600 index closed with little change, after having advanced by as much as 0.7% earlier in the session. Chemical stocks recorded their best single-day performance in nearly four years, fueled by market optimism regarding the region's relaxation of emission reduction rules, which bolstered a rotation into companies with improving growth prospects. Defensive sectors, including telecommunications and consumer staples, also posted gains.

In contrast, technology stocks extended their losing streak, continuing a decline from the previous day when software shares fell due to concerns over the disruptive impact of artificial intelligence. Cellnex Telecom SA rose following its announcement late Tuesday of a new senior management structure, providing a lift to its sector. Mining stocks relinquished their earlier gains to close lower as a rally in metals lost momentum during the final hours of trading.

On an individual stock basis, GlaxoSmithKline climbed 6.9%, buoyed by stronger-than-expected fourth-quarter results driven by its HIV medications and an asthma drug, now approved for treating a lung disease. Novo Nordisk registered its steepest decline since July, erasing over $40 billion in market value and exerting pressure on the healthcare sector.

Santander declined 3.5% after the Spanish bank announced a $12 billion acquisition of Webster Financial Corp. Some analysts expressed concerns that the bank may not be utilizing its capital optimally, while others pointed to potential risks associated with its integration and expansion efforts in the United States.